Compare AbCellera Biologics Inc (ABCL) vs Western Digital Corp (WDC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs Western Digital Corp — how do they compare? AbCellera Biologics Inc trades at $7.26 (market cap $2.35B), while Western Digital Corp trades at $534.33 (market cap $183.41B). The key difference: Western Digital Corp is far larger — about 78× AbCellera Biologics Inc's market cap, and Western Digital Corp pays a 0.11% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | WDC | |
|---|---|---|
Market Cap | $2.35B | $183.41B |
Sector | Health | Technology |
52-Week High | $8.12 | $746.23 |
52-Week Low | $2.78 | $64.02 |
Enterprise Value | $1.99B | $181.75B |
Dividend Yield | — | 0.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) trades at $7.69, down 5.18% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported a net loss of -$146.41M in 2025, with negative margins, though revenue grew to $75.13M. Recent news highlights a major collaboration with Jazz Pharmaceuticals worth up to $876M, potentially boosting future revenue streams. Analyst consensus is strongly bullish with a $9.67 price target, indicating 25.7% upside.
The outlook hinges on execution of new partnerships and pipeline progress, particularly ABCL635 Phase 2 data expected in Q3 2026. Key risks include persistent cash burn, high valuation multiples despite losses, and biotech sector volatility. Investors should weigh the strong analyst support against fundamental challenges and the stock's current technical overbought condition.
Western Digital (WDC) trades at $532.1, down 1.28% amid a sector-wide memory stock sell-off. The stock shows strong fundamentals with three consecutive quarterly earnings beats and a net income margin of 55.07% in 2025. Analyst consensus is strongly bullish with a $607.46 price target, though technical indicators signal near-term bearish pressure with support at $523.
Outlook remains positive driven by AI and data center demand, but volatility from memory pricing cycles and competitive pressures pose risks. Upside depends on continued execution and sector momentum, with the current dip potentially offering entry for growth-oriented investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Western Digital Corp
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →
